ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation

Bi Wei; Zhu Lihong; Wang Chuanming; Liang Yanran; Liu Jun; Shi Qiaoyun; Tao Enxiang*济南大学; 暨南大学
Brain Research2011-6-13DOI: 10.1016/j.brainres.2011.04.019
28被引8阅读
引用收藏
分享

摘要

Microglial activation plays an important role in the pathophysiology of neurodegenerative diseases, and suppression of microglial activation prevents the progression of neurodegeneration. Rifampicin, a bacteriocidal antibiotic, induces immunosuppression. We hypothesized that rifampicin might be neuroprotective by inhibiting the production of pro-inflammatory mediators, thereby suppressing microglial activation. In the present study, we examined the effects of rifampicin on the production of lipopolysaccharide (LPS)-induced pro-inflammatory mediators and their signaling pathways in BV2 microglia. We also assessed the neuroprotective effects of rifampicin using a co-culture of microglia and neurons. Our results showed that rifampicin inhibited the LPS-stimulated expression of inducible nitric oxide synthase, cyclooxygenase-2, tumor necrosis factor-alpha, and interleukin-1 beta, as well as the production of nitric oxide and prostaglandin E(2). Moreover, rifampicin suppressed LPS-induced nuclear factor-kappa B activation by blocking the degradation of the inhibitor of the nuclear transcription factor NF-kappa B. Rifampicin inhibited the phosphorylation of mitogen activated protein kinases, although protein kinase B was not inhibited. Preincubation of microglia with rifampicin reduced neurotoxicity and improved neuron survival in a microglia-neuronal co-culture system. Taken together, these findings suggest that rifampicin, with its anti-inflammatory properties, might be a novel treatment for neurodegenerative diseases.

学科与关键词

关键词
RifampicinMicrogliaNF-kappa BMAPKsNeuronal cellNeuroprotection
相关
加载中…
  • Inhibition of 26S Protease Regulatory Subunit 7 (MSS1) Suppresses Neuroinflammation
    Bi Wei*; Jing Xiuna; Zhu Lihong; Liang Yanran; Liu Jun; Yang Lianhong; Xiao Songhua; Xu Anding; Shi Qiaoyun; Tao EnxiangPLoS ONE, 2012, 7(5): e36142.被引 7
  • Rifampicin and Parkinson's disease
    Bi Wei; Zhu Lihong; Jing Xiuna; Liang Yanran; Tao Enxiang*Neurological Sciences, 2013, 34(2): 137-141.被引 6
  • Remifentanil inhibits the inflammatory response of BV2 microglia and protects PC12 cells from damage caused by microglia activation
    Huang, Yankui; Cai, Qingxiang; Liu, Huihui; Wang, Yong; Ma, Wuhua*Bioengineered, 2022, 13(5): 13944-13955.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Brain Research
发表日期
2011-06-13
卷期
第 1395 卷
页码
12-20
DOI
10.1016/j.brainres.2011.04.019
语言
ENGLISH
成果收录
SCI
资助标注
Guangdong Provincial Department of Science and Technology [0400935505B33801003]; Ph.D. Programs Foundation of Ministry of Education of China [20070558257]

作者

  • B

    Bi Wei (第一作者)

  • Z

    Zhu Lihong

    jinan univ

查看全部 7 位作者收起作者
  • W

    Wang Chuanming

  • L

    Liang Yanran

  • L

    Liu Jun

  • S

    Shi Qiaoyun

  • T

    Tao Enxiang (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417